Tenofovir Disoproxil Fumarate Is Superior to Entecavir in Reducing Hepatitis B Surface Antigen for Chronic Hepatitis B in China: 2-Year Comprehensive Comparative Result of a Matched Comparative Study

Frontiers in Medicine

Fenqiang Xiao¹  Chengwei Cai²  Xueqing Ma³  Sisi Yang³  Huanqiu Wang³  Chengbo Yu³ 

[1] Department of Emergency Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China;Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;

关键词: chronic hepatitis B;    tenofovir disoproxil fumarate;    entecavir;    hepatitis B surface antigen;    hepatocellular carcinoma;    creatinine;   

DOI  :  10.3389/fmed.2021.637126

来源: Frontiers

【 授权许可】

CC BY